Literature DB >> 30519823

The fate of root canals obturated with Thermafil: 10-year data for patients treated in a master's program.

Chiara Pirani1, Fausto Zamparini2, Ove A Peters3, Francesco Iacono2, Maria Rosaria Gatto2, Luigi Generali4, Maria Giovanna Gandolfi2, Carlo Prati2.   

Abstract

OBJECTIVES: Retrospective description of the 10-year success rate of endodontic treatments with Thermafil (TF).
MATERIALS AND METHODS: Patients treated by postgraduate students in an Endodontics Master's Program (2006-2008) were enrolled. All treated root canals were filled with TF and AH Plus. Teeth satisfying the inclusion criteria (206 teeth in 89 patients) were reexamined clinically and radiographically to estimate a 10-year survival and periapical health. Demographic and medical data were registered; collected information included pre-, intra-, and postoperative variables. Teeth were classified as "healthy" (PAI ≤ 2 in absence of signs/symptoms), "endodontically diseased" (presenting at least one of the following: PAI ≥ 3, signs/symptoms, retreated in the course of the follow-up, or extracted for endodontic reasons), or "non-endodontically diseased" (extracted for non-restorable fractures or periodontal disease). For teeth lost during the 10-year follow-up, details and reason of extraction were analyzed. Two PAI-calibrated examiners assessed outcomes blinded to preoperative status. Bivariate and multilevel analyses were performed (α level set at 0.05).
RESULTS: At 10 years, 179 (87%) teeth survived and 27 were extracted: 20 for non-endodontic reasons (excluded from success analysis) and 7 for endodontic reasons (considered "endodontically diseased"). Multilevel analysis revealed that the probability of extraction was increased by the presence of preoperative pain (odds ratio = 6.720; 95% confidence interval, 1.483-30.448) and by maxillary location (odds ratio = 2.950; 95% confidence interval, 1.043-8.347). Concerning periapical status, 159/186 teeth (85%) were assessed as "healthy." Multilevel analysis confirmed that maxillary location (odds ratio = 3.908; 95% confidence interval, 1.370-11.146), presence of flare up (odds ratio = 9.914; 95% confidence interval, 2.388-41.163), and fracture occurrence (odds ratio = 35.412; 95% confidence interval, 3.366-372.555) decreased the odds of healing, respectively.
CONCLUSIONS: After 10 years, teeth filled with Thermafil in a specialist master's program presented a survival and a periapical health comparable to cohorts where root canals were filled with other obturation techniques. CLINICAL RELEVANCE: Carrier-based techniques provide time savings for clinicians while satisfying clinical quality criteria for the root filling and consequently the clinical outcome.

Entities:  

Keywords:  Carrier-based system; Clinical outcome; Long term; Retrospective study; Survival

Mesh:

Year:  2018        PMID: 30519823     DOI: 10.1007/s00784-018-2756-8

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  48 in total

1.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.

Authors: 
Journal:  JAMA       Date:  2000-12-20       Impact factor: 56.272

2.  Comparison of a warm gutta-percha obturation technique and lateral condensation.

Authors:  K Clinton; T Van Himel
Journal:  J Endod       Date:  2001-11       Impact factor: 4.171

3.  Relationship between number of proximal contacts and survival of root canal treated teeth.

Authors:  D J Caplan; J Kolker; E M Rivera; R E Walton
Journal:  Int Endod J       Date:  2002-02       Impact factor: 5.264

4.  Long-term survival of root-canal-treated teeth: a retrospective study over 10 years.

Authors:  Till Dammaschke; Doris Steven; Markus Kaup; Klaus Heinrich Reiner Ott
Journal:  J Endod       Date:  2003-10       Impact factor: 4.171

5.  An analysis of endodontic treatment with three nickel-titanium rotary root canal preparation techniques.

Authors:  O A Peters; F Barbakow; C I Peters
Journal:  Int Endod J       Date:  2004-12       Impact factor: 5.264

6.  A 24-month survey on root canal treatment performed by NiTi engine driven files and warm gutta-percha filling associated system.

Authors:  M A Gagliani; A Cerutti; A Bondesan; M Colombo; E Godio; G Giacomelli
Journal:  Minerva Stomatol       Date:  2004-10

7.  [Studies comparing the efficacy of root canal filling with gutta-percha lateral condensation and Thermafil obturators].

Authors:  M Lipski
Journal:  Ann Acad Med Stetin       Date:  2000

8.  Endodontic treatment outcomes in a large patient population in the USA: an epidemiological study.

Authors:  Robert Salehrabi; Ilan Rotstein
Journal:  J Endod       Date:  2004-12       Impact factor: 4.171

9.  Treatment outcome in endodontics: the Toronto study. Phases I and II: Orthograde retreatment.

Authors:  Mahsa Farzaneh; Sarah Abitbol; Shimon Friedman
Journal:  J Endod       Date:  2004-09       Impact factor: 4.171

10.  Periapical status, prevalence and quality of endodontic treatment in an adult French population.

Authors:  L Lupi-Pegurier; M-F Bertrand; M Muller-Bolla; J P Rocca; M Bolla
Journal:  Int Endod J       Date:  2002-08       Impact factor: 5.264

View more
  3 in total

1.  Assessment of Quality of Root Canal Filling with C Point, Guttacore and Lateral Compaction Technique: A Confocal Laser Scanning Microscopy Study.

Authors:  Sudha Yadav; Ruchika Roongta Nawal; Sarika Chaudhry; Sangeeta Talwar
Journal:  Eur Endod J       Date:  2020-12

2.  Endodontic Tendencies in a Very-Low-Income Population Area of Northeastern Brazil.

Authors:  Maria Tereza Pedrosa Albuquerque; Joice Velames Silva; David Junio Oliveira Poppe; Crislaine Santana Santos; Tainá Pires Santos; Eliseu Aldrigh Münchow; Juliana Yuri Nagata
Journal:  Int J Dent       Date:  2019-09-05

3.  Survival Rates of Endodontically Treated Teeth After Placement of Definitive Coronal Restoration: 8-Year Retrospective Study.

Authors:  Durre Sadaf
Journal:  Ther Clin Risk Manag       Date:  2020-02-21       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.